NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 50 filers reported holding NIVALIS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $90,000 | -95.9% | 40,004 | -85.1% | 0.01% | -93.9% |
| Q3 2016 | $2,176,000 | -26.3% | 267,650 | -58.3% | 0.08% | -46.8% |
| Q2 2016 | $2,951,000 | +6.9% | 641,492 | -3.1% | 0.15% | +11.6% |
| Q1 2016 | $2,761,000 | -29.2% | 662,058 | +31.5% | 0.14% | -35.5% |
| Q4 2015 | $3,898,000 | -21.9% | 503,595 | +30.9% | 0.21% | +3.9% |
| Q3 2015 | $4,990,000 | -23.4% | 384,734 | -10.5% | 0.21% | -13.4% |
| Q2 2015 | $6,515,000 | – | 430,041 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|